Improved Pathologic Diagnosis-Forecasting the Future in Glioblastoma

Front Neurol. 2017 Dec 19:8:707. doi: 10.3389/fneur.2017.00707. eCollection 2017.

¹ Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, NY, United States.
² Department of Neurology, Weill Cornell Medical College, New York, NY, United States.
³ Department of Neurological Surgery, Weill Cornell Medical College, New York, NY, United States.

No abstract available

Keywords: GBM; IDH mutation; MGMT promotor; glioblastoma; molecular diagnostics; whole exome sequencing.